2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-141479B
    Butyryl-Coenzyme A lithium hydrate
    Butyryl-Coenzyme A (Butyryl CoA) lithium hydrate is a short-chain acyl CoA that can synthesize Butyric acid (HY-B0350).
    Butyryl-Coenzyme A lithium hydrate
  • HY-42497
    1,1'-(Butane-1,4-diyl)bis(3-(2-(2-(2-aminoethoxy)ethoxy)ethyl)urea) dihydrochloride
    		99.2%
    1,1'-(Butane-1,4-diyl)bis(3-(2-(2-(2-aminoethoxy)ethoxy)ethyl)urea) dihydrochloride is a drug intermediate for synthesis of various active compounds.
    1,1'-(Butane-1,4-diyl)bis(3-(2-(2-(2-aminoethoxy)ethoxy)ethyl)urea) dihydrochloride
  • HY-Z1119
    Ketoprofen impurity 2
    Ketoprofen impurity 2 is an impurity of Ketoprofen (HY-B0227).
    Ketoprofen impurity 2
  • HY-76245
    1-Methyl-4-(2,4,6-trimethoxyphenyl)piperidin-3-ol
    1-Methyl-4-(2,4,6-trimethoxyphenyl)piperidin-3-ol is a drug intermediate for synthesis of various active compounds.
    1-Methyl-4-(2,4,6-trimethoxyphenyl)piperidin-3-ol
  • HY-118226
    5,6,7,8-Tetrahydro-2-naphthoic acid
    		98.53%
    5,6,7,8-Tetrahydro-2-naphthoic acid is a synthetic intermediate useful for pharmaceutical synthesis.
    5,6,7,8-Tetrahydro-2-naphthoic acid
  • HY-20588
    CRAC intermediate 2
    		99.45%
    CRAC intermediate 2 (the starting compound in example 23) is an intermediate. CRAC intermediate 2 can be used in the research of CRAC inhibitors.
    CRAC intermediate 2
  • HY-W041657
    5-Iodopicolinic acid
    5-Iodopicolinic acid (5-Iodopyridine-2-carboxylic acid) is an organic iodine compound. As an intermediate, 5-Iodopicolinic acid can be used in the synthesis of other active compounds.
    5-Iodopicolinic acid
  • HY-Z3579
    Oseltamivir impurity 68
    		≥98.0%
    Oseltamivir impurity 68 is an impurity of Oseltamivir (HY-13317).
    Oseltamivir impurity 68
  • HY-Z4481
    Sorafenib impurity 4
    Sorafenib impurity 4 is an impurity of Sorafenib (HY-10201).
    Sorafenib impurity 4
  • HY-75204
    2-(3-(Trifluoromethyl)benzamido)acetic acid
    2-(3-(Trifluoromethyl)benzamido)acetic acid is a drug intermediate for synthesis of various active compounds.
    2-(3-(Trifluoromethyl)benzamido)acetic acid
  • HY-I0530
    Canagliflozin impurity 9
    Canagliflozin impurity 9 is an impurity of Canagliflozin (HY-10451).
    Canagliflozin impurity 9
  • HY-75016
    Silane,[[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
    		99.61%
    Silane,[[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl- is a drug intermediate for synthesis of various active compounds.
    Silane,[[(1a,3b,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
  • HY-136665
    Boc-D-Phe-Pro-OH
    		99.51%
    Boc-D-Phe-Pro-OH (tert-Butoxycarbonyl-D-phenylalanyl-L-proline) is a synthetic intermediate useful for pharmaceutical synthesis.
    Boc-D-Phe-Pro-OH
  • HY-I0577
    Cinakase impurity 11
    		99.60%
    Cinakase impurity 11 is an impurity of Cinakase.
    Cinakase impurity 11
  • HY-Z3759
    Vonoprazan impurity 7
    Vonoprazan impurity 7 is an impurity of Vonoprazan (HY-100007).
    Vonoprazan impurity 7
  • HY-75405
    Asenapine impurity 1
    Asenapine impurity 1 is an impurity of Asenapine (HY-10121). Asenapine, an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0). Asenapine can be used in the research of schizophrenia and bipolar disorder.
    Asenapine impurity 1
  • HY-400766
    BWA-522 intermediate-2
    		99.87%
    BWA-522 intermediate-2 is a BWA-522 intermediate. BWA-522 is an orally available small molecule protein-targeting chimera (PROTACs) with significant degradation effect on AR-FL and AR-V7.
    BWA-522 intermediate-2
  • HY-W009807
    1-Chloro-3,5-dimethyladamantane
    		99.75%
    1-Chloro-3,5-dimethyladamantane is an Adamantane (HY-N2427) derivative.
    1-Chloro-3,5-dimethyladamantane
  • HY-W059074
    Pantoprazole impurity 42
    		99.79%
    Pantoprazole impurity 42 is an impurity of Pantoprazole (HY-17507).
    Pantoprazole impurity 42
  • HY-W1116287
    N-Acetyl-Sar24
    N-Acetyl-Sar24 is an acetylated derivative of Sarcosine (HY-101037).
    N-Acetyl-Sar24